Skip to main content
22 Apr | 2022

Biogen, Lilly and Roche visit the new facilities of the BBRC

The pharmaceutical representatives have had a chance to see first-hand the new equipment of the Pasqual Maragall Foundation’s research center

06 Apr | 2022

The BBRC reaches 1,000 lumbar punctures in search for early detection of Alzheimer’s

Lumbar puncture is a procedure to extract cerebrospinal fluid that allows the study of biomarkers of Alzheimer's disease.

22 Mar | 2022

We share the Strategic Plan of the Pasqual Maragall Foundation 2020-2025

From our commitment to transparency, we present the strategic axes and future lines of the Pasqual Maragall Foundation to our participants in studies, partners, collaborators and civil society

21 Mar | 2022

50 researchers from around the world visit the BBRC

On the occasion of the AD / PD 2022 congress, held in Barcelona, ​​the BBRC hosted researchers from all over the world. At the meeting there was a presentation by Prof. Henrik Zetterberg of the University of Gothenburg

14 Mar | 2022

The BBRC, selected as participating center in a new global study on Alzheimer's

This is the AHEAD clinical trial, an international multicenter study to evaluate the efficacy and safety of lecanemab

11 Mar | 2022

El BBRC participa a la 16a International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

AD / PD 2022, held this year in Barcelona, ​​presents work carried out at the Pasqual Maragall Foundation’s research center, in three oral presentations and a poster. In addition, one of our researchers will moderate a symposium of the congress

09 Mar | 2022

BBRC researchers find that carriers of the APOE-ε4 gene accumulate amyloid early in the hippocampus

The study's innovative design has allowed researchers to detect that carriers of the apoe-ε4 gene, linked to an increased risk of developing Alzheimer's, have an accumulation of early amyloid protein in the hippocampal area

01 Mar | 2022

Carriers of the APOE ε2 gene may have a larger brain reserve and better protection against Alzheimer’s

This has been demonstrated in a study by BBRC researchers, published in Alzheimer's & Dementia, in which they have studied the protective effect against malaise and its link to major volumes of gray matter

25 Feb | 2022

The pioneering project of the Clinical Research Unit in Dementia Prevention is coming to an end

The study, which began in May 2018, looked at the risk of developing dementia five years ahead, in people with subjective memory complaints